Rapt Therapeutics Inc
(RAPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 12-2017 | |
| Operating Expenses | 10,959 | 9,544 | 0 | 10,545 | 0 |
| Operating Income | -10,959 | -9,544 | N/A | -10,545 | N/A |
| Other Income | 333 | 356 | 0 | 261 | 0 |
| Pre-tax Income | -10,626 | -9,188 | 0 | -10,284 | 0 |
| Net Income Continuous | -10,626 | -9,188 | N/A | -10,284 | N/A |
| Net Income | $-10,626 | $-9,188 | $N/A | $-10,284 | $N/A |
| EPS Basic Total Ops | -118.24 | -106.24 | N/A | -127.20 | N/A |
| EPS Basic Continuous Ops | -118.23 | -106.25 | N/A | -127.20 | N/A |
| EPS Diluted Total Ops | -118.24 | -106.24 | N/A | -127.20 | N/A |
| EPS Diluted Continuous Ops | -118.23 | -106.25 | N/A | -127.20 | N/A |
| EBITDA(a) | $-10,621 | $-9,213 | $N/A | $-10,545 | $N/A |